Experimental therapy of cardiac remodeling with quercetin-containing drugs

  • M.A. Kuzmenko Bogomoletz Institute of Physiology, 4, Bogomoletz str., Kyiv, 01024, Ukraine
  • V.B. Pavlyuchenko Bogomoletz Institute of Physiology, 4, Bogomoletz str., Kyiv, 01024, Ukraine
  • L.V. Tumanovskaya Bogomoletz Institute of Physiology, 4, Bogomoletz str., Kyiv, 01024, Ukraine
  • V.E. Dosenko Bogomoletz Institute of Physiology, 4, Bogomoletz str., Kyiv, 01024, Ukraine
  • A.A. Moybenko Bogomoletz Institute of Physiology, 4, Bogomoletz str., Kyiv, 01024, Ukraine
Keywords: cardiac remodeling, bioflavonoids, fibrosis, cardiac function

Abstract

It was shown that continuous beta-adrenergic hyperstimulation resulted in cardiac function disturbances and fibrosis of cardiac tissue. Treatment with quercetin-containing drugs, particularly, water-soluble corvitin and tableted quertin exerted favourable effect on cardiac hemodynamics, normalized systolic and diastolic function in cardiac remodeling, induced by sustained beta-adrenergic stimulation. It was estimated that conducted experimental therapy limited cardiac fibrosis area almost three-fold, that could be associated with first and foremost improved cardiac distensibility, characteristics of diastolic and also pump function in cardiac remodeling.

Downloads

Download data is not yet available.
Published
2013-06-19
How to Cite
Kuzmenko M., Pavlyuchenko V., Tumanovskaya L., Dosenko V., Moybenko A. Experimental therapy of cardiac remodeling with quercetin-containing drugs // Patologicheskaya Fiziologiya i Eksperimental’naya Terapiya (Pathological physiology and experimental therapy). 2013. VOL. 57. № 2. PP. 17–22.
Section
Original research